NCT03631017 2025-09-03
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT04538950 2023-09-13
PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
Mayo Clinic
Phase 1/2 Completed
NCT03665155 2021-07-30
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT03511768 2018-04-30
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Xiangya Hospital of Central South University
Phase 1/2 Unknown